Novartis AG Proceeds From Other Longterm Assets Classified As Investing Activities
Novartis AG (NVSEF) reported Proceeds From Other Longterm Assets Classified As Investing Activities of $3.00 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-01-31.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities · last filed 2025-01-31
- Novartis AG proceeds from other longterm assets classified as investing activities for the quarter ending 2021-06-30 was $3.00M.
- Novartis AG proceeds from other longterm assets classified as investing activities for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- Novartis AG proceeds from other longterm assets classified as investing activities for the quarter ending 2018-06-30 was $4.00M.
- Novartis AG proceeds from other longterm assets classified as investing activities for the quarter ending 2017-06-30 was $0.00.
| Period end | Proceeds From Other Longterm Assets Classified As Investing Activities 3 month | Proceeds From Other Longterm Assets Classified As Investing Activities 6 month | Proceeds From Other Longterm Assets Classified As Investing Activities 12 month |
|---|---|---|---|
| 2024-12-31 | $3.00M 20-F · filed 2025-01-31 | ||
| 2021-12-31 | $4.00M 20-F · filed 2024-01-31 | ||
| 2021-06-30 | $3.00M 6-K · filed 2022-07-19 | $3.00M 6-K · filed 2022-07-19 | |
| 2020-12-31 | $2.00M 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $0.00 6-K · filed 2021-07-21 | ||
| 2019-12-31 | $3.00M 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $0.00 6-K · filed 2019-07-18 | $3.00M 6-K · filed 2020-07-21 | |
| 2018-12-31 | $9.00M 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $4.00M 6-K · filed 2019-07-18 | $4.00M 6-K · filed 2019-07-18 | |
| 2017-12-31 | $1.00M 20-F · filed 2020-01-29 | ||
| 2017-06-30 | $0.00 6-K · filed 2018-07-18 | $1.00M 6-K · filed 2018-07-18 | |
| 2015-12-31 | $1.00M 6-K · filed 2018-01-24 |